<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D6235C0A-8C87-4829-ACF2-8BDE531C2B35"><gtr:id>D6235C0A-8C87-4829-ACF2-8BDE531C2B35</gtr:id><gtr:name>Ondine Biomedical Inc.</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:department>Chemistry</gtr:department><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D6235C0A-8C87-4829-ACF2-8BDE531C2B35"><gtr:id>D6235C0A-8C87-4829-ACF2-8BDE531C2B35</gtr:id><gtr:name>Ondine Biomedical Inc.</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/D82D3871-9D37-493B-BF55-2F3C2EC50BB1"><gtr:id>D82D3871-9D37-493B-BF55-2F3C2EC50BB1</gtr:id><gtr:firstName>Alexander</gtr:firstName><gtr:otherNames>John</gtr:otherNames><gtr:surname>MacRobert</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/ABFE56B5-A1F9-4DF8-AA84-E4E845958E08"><gtr:id>ABFE56B5-A1F9-4DF8-AA84-E4E845958E08</gtr:id><gtr:firstName>C A  Sandy</gtr:firstName><gtr:surname>Mosse</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/D7CF0B30-B039-4ADB-B20F-6E2F353BC27C"><gtr:id>D7CF0B30-B039-4ADB-B20F-6E2F353BC27C</gtr:id><gtr:firstName>Ivan</gtr:firstName><gtr:otherNames>Paul</gtr:otherNames><gtr:surname>Parkin</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/6F761512-C068-4DE5-B0A4-99E882912AB1"><gtr:id>6F761512-C068-4DE5-B0A4-99E882912AB1</gtr:id><gtr:firstName>Christopher</gtr:firstName><gtr:otherNames>William</gtr:otherNames><gtr:surname>Kay</gtr:surname><gtr:orcidId>0000-0002-5200-6004</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/2F11D766-ADB1-4F66-9A0A-DDCEB29264F5"><gtr:id>2F11D766-ADB1-4F66-9A0A-DDCEB29264F5</gtr:id><gtr:firstName>Michael</gtr:firstName><gtr:surname>Wilson</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0902208"><gtr:id>6D599A1F-490B-453B-95B5-E6C60FF12DB2</gtr:id><gtr:title>The use of light activated antimicrobials to prevent catheter related infection</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0902208</gtr:grantReference><gtr:abstractText>This project is focussed on reducing catheter acquired infection or CAI. These infections are widespread in the NHS and are particularly prevelant in newborns and the elderly. Our project seeks to reduce these infections through a new approach that uses a light source and a new class of catheter. This catheter has embedded dye molecules that under the action of light produce species that are toxic to bacteria. These catheters are self sterilising and most importantly show the ability to resist the biofilm formation that is the precursor to infection. It has been determined that catheter born infections are the most common cause of hospital acquired infection in the UK.</gtr:abstractText><gtr:technicalSummary>This proposal seeks to reduce catheter acquired infections through the construction of a new class of catheter. These catheters have embedded light activated antimicrobial molecules in tandem with gold nanoparticles. Under the action of white light (from an LED) or laser source these catheters kill bacteria though the production of reactive oxygen species. Furthermore the new catheter surface prevents bacterial adhesion and has been shown to be able to remove a biofilm. This project aims to optimise the formation of the best antimicrobial catheter by optimisation of the LAAA- gold photosensitiser, develop the best light delivery method and incorporate these into a prototype device. We seek to do preclinical studies of the prototype device including appropriate animal testing.</gtr:technicalSummary><gtr:fund><gtr:end>2013-12-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2011-02-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>770721</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Ondine Biomedical Inc.</gtr:collaboratingOrganisation><gtr:country>Canada</gtr:country><gtr:description>Ondine</gtr:description><gtr:id>3A65D2E4-C6F0-4342-B6DA-88FC3DEB6418</gtr:id><gtr:impact>Not at this stage</gtr:impact><gtr:outcomeId>gVHxhWzZaoa-1</gtr:outcomeId><gtr:piContribution>Access to data and equipment loans</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>2482246</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EPSRC healthcare technologies call</gtr:description><gtr:end>2019-06-02</gtr:end><gtr:fundingOrg>Engineering and Physical Sciences Research Council (EPSRC)</gtr:fundingOrg><gtr:fundingRef>EP/M105157</gtr:fundingRef><gtr:id>F490553A-142E-4A98-A46A-128E935065D5</gtr:id><gtr:outcomeId>56c2ea99b71a17.46772411</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-06-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>Antimicrobial coating</gtr:description><gtr:grantRef>G0902208</gtr:grantRef><gtr:id>212D9B81-2DD7-42A4-B75E-2885B88B53F6</gtr:id><gtr:impact>ondine have started hospital trials in vancouver</gtr:impact><gtr:licensed>Yes</gtr:licensed><gtr:outcomeId>GN6BN6y17J6</gtr:outcomeId><gtr:patentId>US2008031960</gtr:patentId><gtr:protection>Patent granted</gtr:protection><gtr:title>Antimicrobial coating</gtr:title><gtr:yearProtectionGranted>2008</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>new antimicrobial coating</gtr:description><gtr:id>9CE9FE04-928E-4828-A382-555577D42367</gtr:id><gtr:impact>The materials has gone through a clinical trial at UCH and shown to reduce bacteria in the environment. A second clinical trial has stated.</gtr:impact><gtr:outcomeId>rfEkLdKh11V</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>new antimicrobial formulation</gtr:title><gtr:type>Physiological assessment or outcome measure</gtr:type><gtr:yearFirstProvided>2012</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>2EBD1C1C-3000-4893-80BC-E2FA07098265</gtr:id><gtr:title>Comparative study of singlet oxygen production by photosensitiser dyes encapsulated in silicone: towards rational design of anti-microbial surfaces.</gtr:title><gtr:parentPublicationTitle>Physical chemistry chemical physics : PCCP</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/eda11607ddaf64bf33ff67edb56b13d4"><gtr:id>eda11607ddaf64bf33ff67edb56b13d4</gtr:id><gtr:otherNames>Noimark S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1463-9076</gtr:issn><gtr:outcomeId>585d36838a1867.48694419</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A02DAB1D-AC8F-4C51-808B-B3CD55926E22</gtr:id><gtr:title>Visible Light Photocatalytic Activity in AACVD-Prepared N-modified TiO
 
 Thin Films</gtr:title><gtr:parentPublicationTitle>Chemical Vapor Deposition</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/091b01d62fcb8df9e47fde78797e658c"><gtr:id>091b01d62fcb8df9e47fde78797e658c</gtr:id><gtr:otherNames>Diesen V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>546229f7ad5a88.95241746</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7CAFEC7A-111C-40B6-BF0F-6D676DF4C75B</gtr:id><gtr:title>Shining light on materials--a self-sterilising revolution.</gtr:title><gtr:parentPublicationTitle>Advanced drug delivery reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/eda11607ddaf64bf33ff67edb56b13d4"><gtr:id>eda11607ddaf64bf33ff67edb56b13d4</gtr:id><gtr:otherNames>Noimark S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0169-409X</gtr:issn><gtr:outcomeId>doi_16056_012_07_003</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B242038F-1B5E-49CA-95C3-F30E2ABF7EBB</gtr:id><gtr:title>Photobactericidal polymers; the incorporation of crystal violet and nanogold into medical grade silicone</gtr:title><gtr:parentPublicationTitle>RSC Advances</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/eda11607ddaf64bf33ff67edb56b13d4"><gtr:id>eda11607ddaf64bf33ff67edb56b13d4</gtr:id><gtr:otherNames>Noimark S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>545b684c88a0f8.74859164</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>395B1356-3590-4D56-9F2B-E523537F3DB7</gtr:id><gtr:title>Photosensitisation studies of silicone polymer doped with methylene blue and nanogold for antimicrobial applications</gtr:title><gtr:parentPublicationTitle>RSC Advances</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4bcd257539c9611d54e5b76c76356440"><gtr:id>4bcd257539c9611d54e5b76c76356440</gtr:id><gtr:otherNames>Bovis M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:outcomeId>56d0303a15c278.29575389</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BECD9CE2-6FBD-43B9-ABD5-5ECD87DD428E</gtr:id><gtr:title>Silver enhanced TiO2 thin films: photocatalytic characterization using aqueous solutions of tris(hydroxymethyl)aminomethane.</gtr:title><gtr:parentPublicationTitle>Dalton transactions (Cambridge, England : 2003)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/091b01d62fcb8df9e47fde78797e658c"><gtr:id>091b01d62fcb8df9e47fde78797e658c</gtr:id><gtr:otherNames>Diesen V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1477-9226</gtr:issn><gtr:outcomeId>54622abb346242.08552582</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B71AD4DD-D61E-44C6-8CC7-D58819037795</gtr:id><gtr:title>Potent Antibacterial Activity of Copper Embedded into Silicone and Polyurethane.</gtr:title><gtr:parentPublicationTitle>ACS applied materials &amp; interfaces</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/579d667d1d53b096474a522533866e86"><gtr:id>579d667d1d53b096474a522533866e86</gtr:id><gtr:otherNames>Sehmi SK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1944-8244</gtr:issn><gtr:outcomeId>56d02d2190afd4.18705720</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0902208</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>93E3E424-8678-4BDD-9675-2EA16B3EFEA4</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>5.3  Medical devices</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>